Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Espen Fengsrud"'
Autor:
Demir Djekic, Martin Lindgren, N. David Åberg, Maria Åberg, Espen Fengsrud, Dritan Poci, Martin Adiels, Annika Rosengren
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 21 (2022)
Background We sought to determine the role of obesity in adolescent men on development of atrial fibrillation (AF) and subsequent associated clinical outcomes in subjects diagnosed with AF. Methods and Results We conducted a nationwide, register‐ba
Externí odkaz:
https://doaj.org/article/e514a80b08b842a2a21470b489a7662b
Publikováno v:
Heart Rhythm O2. 3:766-770
Catheter ablation for treatment of atrial fibrillation (AF), AF ablation, is more effective than antiarrhythmic drugs in reducing AF burden, reducing symptoms and increasing health-related quality of life. Although females more often experience AF-re
Publikováno v:
Pacing and Clinical Electrophysiology.
Publikováno v:
Scandinavian cardiovascular journal : SCJ. 56(1)
To evaluate the correlation of a' velocity by tissue-Doppler measurements with invasively measured mean left atrial pressure in patients with normal ejection fraction.In this retrospective study, we evaluated the septal a', lateral a' and average a'
Autor:
Runa Sigurjonsdottir, Jonas Carlson, Carina Blomström-Lundqvist, Michael Ringborn, Per Insulander, Ole Kongstad, Dritan Poçi, Csaba Herczku, Anders Englund, Lars Karlsson, Göran Kennebäck, Anders Jönsson, Milos Kesek, Fredrik Holmqvist, Espen Fengsrud, Romeo Samo-Ayou, Fariborz Tabrizi, Niklas Höglund, Stefan Lönnerholm
Publikováno v:
European Heart Journal
Aims Catheter ablation is considered the treatment of choice for many tachyarrhythmias, but convincing real-world data on efficacy and safety are lacking. Using Swedish national registry data, the ablation spectrum, procedural characteristics, as wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b86b20355bb02b060084d41a74614ae
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-367225
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-367225
Publikováno v:
Scandinavian Cardiovascular Journal. 51:21-27
To study pre- and postoperative atrial fibrillation and its long-term effects in a cohort of aortocoronary bypass surgery patients.Altogether 615 patients undergoing aortocoronary bypass graft surgery in 1999-2000 were studied. Forty-four (7%) had pr
Publikováno v:
Interactive CardioVascular and Thoracic Surgery. 23:292-298
Total endoscopic ablation of atrial fibrillation is an alternative to catheter ablation, but its clinical role needs further evaluation. The aim of this study was to compare total endoscopic ablation with rate control in patients with long-standing p
Autor:
Henrik Almroth, Anders Englund, Mårten Rosenqvist, Leif Friberg, Peter Linde, Espen Fengsrud, Torbjörn Andersson
Publikováno v:
Journal of Internal Medicine. 270:281-290
Almroth H, Andersson T, Fengsrud E, Friberg L, Linde P, Rosenqvist M, Englund A (Orebro University Hospital, Orebro; Danderyd Hospital and Karolinska Institutet at Danderyd Hospital, Stockholm; and Karolinska Institutet at Stockholm South Hospital, S
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 37:1353-1359
This article presents a study of postoperative atrial fibrillation (AF) and its long-term effects on mortality and heart rhythm.The study cohort consisted of 571 patients with no history of AF who underwent primary aortocoronary bypass surgery from 1
Autor:
Job Harenberg, Paul Matthew Pasco, Mario Talajic, Leopoldo Piegas, Kosta Kostov, Ales Tomek, Konstantin Ramshev, Cetin Erol, David McEneaney, Julián Pérez-Villacastín, Tilemachos Zafeiridis, Salim Yusuf, Espen Fengsrud, David Halon, Graeme Hankey, Ru San Tan, David Tanne, ALVARO AVEZUM, Antonis Manolis, Fabio Turazza, Grethe Andersen, John Eikelboom, Valentin Kokorin, Juan Manuel Escudier Villa, JOSEP BRUGADA, Luis Cunha, Joaquin J Alonso, Stefan Engelter, Pedro Adragao, Geert Vanhooren, Sergey Golitsyn, Andrzej Budaj, Sam Schulman
Publikováno v:
Connolly, S J, Ezekowitz, M D, Yusuf, S, Eikelboom, J, Oldgren, J, Parekh, A, Pogue, J, Reilly, P A, Themeles, E, Varrone, J, Wang, S, Alings, M, Xavier, D, Zhu, J, Diaz, R, Lewis, B S, Darius, H, Diener, H-C, Joyner, C D, Wallentin, L, RE-LY Steering Committee and Investigators & Rasmussen, L H 2009, ' Dabigatran versus warfarin in patients with atrial fibrillation ', The New England Journal of Medicine, vol. 361, no. 12, pp. 1139-51 . https://doi.org/10.1056/NEJMoa0905561
New England journal of medicine, 361(12), 1139-1151. Massachussetts Medical Society
New England journal of medicine, 361(12), 1139-1151. Massachussetts Medical Society
Udgivelsesdato: 2009-Sep-17 BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor. METHODS: In this noninf